Delivery Order SPE2DB20D2104-SPE2DB25FNBSL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for $2,491.38 to supply Tresiba FlexTouch 200 unit/mL 3mL insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,491.38 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 Unit/ML insulin pens (3 ML). This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,491.38 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, firm fixed-price contract represents a small-value pharmaceutical procurement with no set-aside designation. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,143.19 by the Defense Logistics Agency on September 11, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 12, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $2,076.30 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.59 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This was a competitively awarded, non-set-aside firm fixed price contract with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,212.81 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This firm fixed price, non-set-aside contract is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,982.76 delivery order to AmerisourceBergen Drug Corp for TRESIBA FLEXTOUCH 200 Unit/ML 3ML insulin pens, with an ultimate completion date of July 23, 2025. This non-set-aside contract utilizes a firm fixed-price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,384.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBSLDelivery Order
The Defense Logistics Agency awarded a $1,211.75 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The order was fulfilled at the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to deliver critical medications and medical commodities to support Defense Health Agency and other government healthcare systems through flexible and competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/26/25 |